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Mitochondrial diseaseMitochondria play an integral role in cell death signaling, yet how mitochondrial defects disrupt this impor-
tant function is not well understood. We have used a mouse L-cell ﬁbroblast model harboring Rattus
norvegicusmtDNA (Rn xenocybrids) to examine the effects of multiple oxidative phosphorylation (OXPHOS)
defects on reactive oxygen species (ROS) generation and cell death signaling. Blue native-PAGE analyses of
Rn xenocybrids revealed defects in OXPHOS complex biogenesis with reduced steady-state levels of
complexes I, III and IV. Isolated Rn xenocybrid mitochondria exhibited deﬁciencies in complex II + III
and III activities, with CIII-stimulated ROS generation 66% higher than in control mitochondria. Rn xenocybrid
cells were resistant to staurosporine-induced cell death, but exhibited a four-fold increase in sensitivity to
ceramide-induced cell death that was caspase-3 independent and did not induce chromosomal DNA degra-
dation. Furthermore, ceramide directly inhibited Rn xenocybrid complex II + III activity by 97%, although
this inhibition could be completely abolished by exogenous decylubiquinone. Ceramide also induced a fur-
ther increase in ROS output from Rn xenocybrid complex III by 42%. These results suggest that the interaction
of ceramide with OXPHOS complex III is signiﬁcantly enhanced by the presence of the xenotypic Rattus
cytochrome b in complex III, likely due to the increased afﬁnity for ceramide at the ubiquinone binding site.
We propose a novel mechanism of altered mitochondrial cell death signaling due to mtDNAmutations whereby
ceramide directly induces OXPHOS complex ROS generation to initiate cell death pathways.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Much of a cell's energy requirements are met by the mitochondria,
organelles which can oxidize sugars, fats and amino acids to generate
ATP. This metabolic process, termed oxidative phosphorylation
(OXPHOS), is performed by a series of ﬁve enzyme complexes within
the mitochondrial inner membrane. These complexes contain multiple
protein subunits, encoded by both the nuclear genome and the
mitochondria's own DNA (mtDNA), whichmust be assembled together
in a coordinated fashion to form the mature holocomplexes. Mutations
in either nuclear or mtDNA can cause OXPHOS complex deﬁciencies,
resulting in metabolic disorders that affect approximately 1 in 5000S, oxidative phosphorylation;
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rights reserved.live births [1,2]. These disorders encompass a wide variety of multi-
systemic degenerative diseases, commonly referred to as mitochondri-
al encephalomyopathies, which can exhibit various combinations of
clinical features. Brain and muscle are usually affected, although other
tissues that have high energy requirements may also be involved.
Although biochemical defects have been associated with various
mtDNA mutations, secondary effects, such as elevated ROS production,
may also modulate the primary OXPHOS deﬁciency. For example, the
MTND1 and MTND6 mutations associated with Leber Hereditary Optic
Neuropathy (LHON) [3,4] alter the binding of CoQ10 to complex I,
resulting in increased levels of ubisemiquinone and ROS generation
which in turn may contribute to the premature death of the optic
nerve [5]. Increased ROS generation has also been observed in differen-
tiated NT2 neurons containing MTND4 or MTND1 LHON mutations [6]
with a concomitant increase in sensitivity to Fas-induced apoptosis
[7]. Other mtDNA mutations, such as a 4 bp deletion in the cyto-
chrome b gene associated with complex III deﬁciency in a patient
with Parkinsonism, are also associated with increased ROS generation
[8]. These results suggest that elevated ROS levels, due to mtDNA
mutation-induced OXPHOS defects, contribute to disease pathology.
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in the ‘mtDNA mutator’ mouse (which has high levels of mtDNA
mutations and deletions due to a knock-in mutation in the PolgA gene)
is not associated with increased ROS generation [9].
One important molecule that has been implicated in ROS-linked
cell-death signaling is ceramide, a lipid produced by either de novo
synthesis or from the breakdown of sphingomyelin after activation
of sphingomyelinase (which is classically induced by the TNFα
death receptor [10]). Cell permeant ceramide analogs (C2 and C6)
have been shown to induce cell death that exhibits either apoptotic
or necrotic features depending on cell type [11–14] and to increase
mitochondrial ROS production during cell death [15–18]. NADH-
and FADH-linked respiration of rat heart mitochondria is inhibited
by C2- and C6-ceramide, with ceramide also directly inhibiting com-
plex I and III enzymatic activity [16,19–21].
Although the effects of ceramide are well known, ceramide-
induced cell death signaling consequent to mtDNA mutations has
not been investigated. To examine these effects, in vitro and in vivo
mouse models of mtDNA disease would be highly beneﬁcial. However,
the unique features of mitochondrial genetics, including the high cellu-
lar mtDNA copy number and the lack of demonstrated mechanisms of
recombination, have presented technical hurdles to producing designer
mtDNA mutant mouse cells [22]. To overcome these barriers, we have
used a xenomitochondrial cybrid cell model which has a nuclear
genome from Mus musculus and mtDNA from Rattus norvegicus (‘Rn’
xenocybrid). The Rn xenocybrid contains 453 amino acid changes in
its 13 mtDNA-encoded subunits compared to M. musculus, resulting
in nuclear/mtDNA incompatibilities that cause severe mitochondrial
OXPHOS defects [23]. Although the multiple amino acid changes in
xenocybrid cells do not model single pathogenic mtDNA mutations
per se, they are a valuable tool for investigating OXPHOS complex
deﬁciencies [24]. Furthermore, the xenocybrid system can be transferred
to mouse ES cells to generate live xenomitochondrial mouse models for
comparative in vivo studies [25].
We have used Rn xenocybrid cells here to investigate the effects of
OXPHOS deﬁciencies on cell death and ROS generation. Rn xenocybrids
have disrupted assembly of the OXPHOS complexes, with reduced
steady-state levels of mature complexes I, III and IV. This is associated
with complex I and III enzymatic defects and increased basal levels of
ROS production. In addition, Rn xenocybrid mitochondria exhibited
an increased sensitivity to C2-ceramide compared to control cybrid mi-
tochondria, with ceramide-mediated inhibition of OXPHOS complex III
further increasing the ROS output at this complex. This inhibition could
be abolished by addition of the ubiquinone analogue decylubiquinone.
The ceramide-inhibition of OXPHOS function and stimulation of
ROS production were associated with a four-fold higher rate of cell
death compared with control cybrids cells. These results indicate that
complex III defects consequent to mtDNA mutations (i.e. in the mtDNA
cytochrome b gene) can increase oxidative stress and sensitivity to cell
death induced by the ceramide signaling pathway.
2. Materials and methods
2.1. Reagents
Unless otherwise speciﬁed, all chemicals were purchased from
Sigma (USA).
2.2. Cell lines and culture conditions
All cells were grown in RPMI 1640 medium (Life Technologies, USA)
supplemented with 10% fetal bovine serum (fbs) (Life Technologies),
4.5 g/L glucose, 50 mg/L uridine and 1 mM pyruvate (RPMI/GUP medi-
um) at 37 °C and 5% CO2. Mouse xenocybrids were created by fusing a
mtDNA-less cell line (ρ0) with a variety of cytoplast donors. The ρ0
clone used in these experiments, designated LMEB3, was producedfrom the parental line LMTK- by exposure to ethidium bromide [26]. A
Mus musculus domesticus primary ﬁbroblast line was used as a mito-
chondrial donor to create a control cybrid while a R. norvegicusmamma-
ry tumor line (RN1T, obtained from ATCC) was used to create a cybrid
with a severe respiratory defect (Rn xenocybrid). These lines, fusions
and resulting xenocybrids are described in detail elsewhere [23]. For
cell death induction experiments, cells were grown in RPMI 1640
medium supplemented with 1% fbs and 2 mM L-Glutamine (treatment
medium) with the addition of 25 μM C2-ceramide (25 mM stock
solution in DMSO) or 150 nM staurosporine (150 μM stock in DMSO)
for the times indicated. Final concentration of DMSO in the treatment
medium was 0.1% (v/v).
2.3. Radiolabeling of mitochondrial DNA-encoded subunits
Mitochondrial DNA-encoded translation products were speciﬁ-
cally labeled as described previously [27]. In brief, cells were pre-
treated with 50 μg/mL chloramphenicol (CAP) in DMEM containing
10% (v/v) fbs for 24 h before incubation with 0.1 mg/mL cyclohexi-
mide in methionine-free DMEM containing 5% (v/v) dialyzed fbs for
15 min at 37 °C. Labeling was performed by the addition of 20 μCi of
35S-methionine/35S-cysteine (EXPRE35S35S Protein Labeling Mix;
Perkin Elmer Life Sciences, USA) for 2 h, followed by addition of
cold methionine to a ﬁnal concentration of 1 mM. After 15 min,
the solution was removed and replaced with DMEM/5% (v/v) fbs
for extended chase times.
2.4. Blue native polyacrylamide gel electrophoresis (BN-PAGE)
BN-PAGE was performed as described with minor modiﬁcations
[28]. Mitochondria (50 μg protein) were solubilized for 30 min on ice
in 50 μL of 20 mM Bis–Tris pH 7.4, 50 mM NaCl, 10% (v/v) glycerol
containing 1% (v/v) Triton X-100. Insoluble material was removed by
centrifugation at 18000 g for 5 min at 4 °C, with the soluble component
combined with BN-PAGE loading dye (ﬁnal concentrations: 0.5% (w/v)
Coomassie Blue G, 50 mM ε-amino n-caproic acid, 10 mM Bis–Tris pH
7.0) and separated on a 4–13% acrylamide–bisacrylamide BN-PAGE gel
made up in 70 mM ε-amino n-caproic acid, 50 mM Bis–Tris (pH 7.0).
For separation, cathode buffer (15 mM Bis–Tris pH 7.0, 50 mM tricine)
containing 0.02% (w/v) Coomassie Blue G was used until the dye front
had reached approximately one-third of the way through the gel before
exchange with colorless cathode buffer. Anode buffer contained 50 mM
Bis–Tris pH 7.0. Native complexes were separated at 100 V/5 mA for
13.5 h at 4 °C. For two-dimensional PAGE, BN-PAGE strips were posi-
tioned into the stacker of a 10–16% polyacrylamide Tris–tricine gradient
gel. Samples were separated in the 2nd dimension at 100 V/25 mA for
14 h.
2.5. Western transfer and immunodetection
Western blotting was performed using a semi-dry transfer method
[29] with modiﬁcations as previously described [30]. Mouse monoclo-
nal antibodies to mitochondrial respiratory chain subunits (Life Tech-
nologies) included the α-subunit (complex V), NDUFS2 (complex I),
SDHA (complex II), Core I (complex III) and CO1 (complex IV). Rabbit
polyclonal antibodies to human NDUFA9 were raised against re-
combinant, bacterially expressed protein as previously described [31].
Secondary probing with anti-mouse or anti-rabbit HRP conjugated an-
tibody was performed for 2 h followed by detection using ECL reagents
(GE Healthcare, NJ, USA) and a MicroChemi Imaging System (DNR
Bio-Imaging Systems, Israel).
2.6. Cell death markers
Hoechst 33342 staining was performed on cells grown in 8-well
chamber slides. Cells were washed in ice cold PBS, treated for 5 min
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binding buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 5 mM KCl,
1 mM MgCl2, 1.8 mM CaCl2), then washed twice for 2 min in 1×
binding buffer. Cells were visualized and counted using UV excitation
(340–380 nm) on a Leica DMRB microscope.
Caspase-3 activity wasmeasured using the ‘EnzChek Caspase-3 Assay
Kit #1’ (Life Technologies) following the manufacturer's instructions.2.7. Isolation and electrophoresis of DNA for DNA laddering assay
DNA was isolated from cell pellets by phenol/chloroform extraction
following proteinase K digestion as previously described [26]. 10 μg of
DNA was resolved in a 2% agarose gel in 1× TAE at 70 V.2.8. Mitochondrial isolation
Cell cultures were expanded to around 109 cells in roller bottles
and mitochondria isolated using digitonin lysis and differential cen-
trifugation [23]. Final mitochondrial preparations were resuspended
to around 20 mg/mL protein in isolation buffer and frozen in aliquots
at −80 °C. Preparations of sub-mitochondrial particles (SMPs) used
for enzyme activity and ROS assays were created by thawing the mi-
tochondrial preparations and diluting to 1 mg/mL in isolation buffer.2.9. Determination of respiratory chain activities and ceramide inhibition
Determination of OXPHOS complex I, II, II + III, and III activities
were as previously described [32]. For complex I, n-dodecyl β-D-
maltoside was included in the reaction mixture at a concentration
of 0.01% (w/v) and rotenone-sensitive activity was determined with
the addition of 1 μg/ml rotenone. For ceramide inhibition experiments,
C2-ceramide was added to the reaction mixtures prior to initiating
enzyme activity. In some complex II + III assays (which utilize endoge-
nous ubiquinone as the electron carrier), the endogenous ubiquinone
was supplemented by adding 0.5 to 50 μM exogenous decylubiquinone.2.10. Fluorimetric determination of ROS production in isolated mitochondria
using DCFH
2′,7′-Dichlorodihydroﬂuoroscein diacetate (H2DCFDA) (Life
Technologies, USA) was dissolved in DMSO at 50 mM. A 200 μM
DCFH solution was created by diluting the 50 mM H2DCFDA stock
solution to 1 mM in methanol (100 μL), then adding 400 μL of
10 mM NaOH. This solution was left at room temperature for
30 min to deacetylate. The resulting 200 μM DCFH was used within
1 h for the detection of complex I- and complex III-mediated H2O2
generation. Complex I and III assays were performed as described
above except that KCN, a known inhibitor of superoxide dismutase
[33], was omitted and superoxide dismutase added at 10 U/mL. Com-
plex I and III activities (in a reaction mixture of 950 μL) were allowed
to proceed for 5 min before the addition of 50 μL of 200 μMDCFH and
incubation at 30 °C for 2 h. H2O2-mediated oxidation of DCFH to
ﬂuorescent DCH was measured in 300 μL aliquots of the reaction
mixtures using a Wallac Victor2 1420 plate reader (excitation
485 nm/emission 535 nm). Where required, the following additions
and deletions were made to the 1 mL complex I and III reaction mix-
tures prior to initiating the enzyme complex activities: 30 U catalase
added; 25 μM C2-ceramide (or an equal volume of DMSO) added;
SMPs omitted and replaced with an equal volume of isolation buffer;
10 mM KCN added.
All complex I and III DCFH oxidation results are SMPs-dependent
and catalase-sensitive.2.11. Protein structure modeling
Amino acid differences between M. musculus and R. norvegicus in
the mtDNA-encoded cytochrome b protein were modeled using the
Deep View — Swiss-PDB Viewer [34].
3. Results
3.1. The Rn xenocybrid has reduced levels of steady-state OXPHOS
complexes
To determine the steady-state levels of the respiratory chain com-
plexes, isolated Mm control cybrid or Rn xenocybrid cell mitochondria
were solubilized in Triton X-100 followed by blue native polyacrylamide
gel electrophoresis (BN-PAGE) and Western blot analysis (Fig. 1A). In
this detergent the respiratory chain complexes mainly resolve in their
monomeric forms (or as a homodimer for complex III2 [30]). The
amount of mature complex I and complex IV in Rn xenocybrid mito-
chondria was severely decreased compared to control, with the complex
III2 dimer undetectable under these conditions. This is consistent with
the complex I, II + III and IV enzymatic defects previously described
in these xenocybrid cells [23].
3.2. The Rn xenocybrid has defects in OXPHOS complex biogenesis
Pulse-chase radiolabeling was performed to examine mtDNA-
encoded protein translation and the subsequent assembly of these
newly-translated products into their respective mature OXPHOS
complexes. Labeling was conducted for 2 h, followed by a chase of ei-
ther 0 or 24 h (Fig. 1B). Compared to the control Mm cybrid (Fig. 1B,
lane 1), the Rn xenocybrid (lane 3) exhibited reduced amounts of
newly-translated CO2, CO3 and cyt b (as has been shown previously
[23]). The translation of the other mtDNA-encoded subunits of com-
plex I (ND1, ND2, ND3, ND5, ND6), complex IV (CO1) and complex
V (ATP6 and ATP8) was similar in control Mm cybrid and Rn
xenocybrid mitochondria. Of note, ND4L and ATP8 resolve at the
same position in Mm cybrid mitochondria (Fig. 1B, lanes 1 and 2)
but at different positions in Rn xenocybrid mitochondria (lanes 3
and 4) under these electrophoresis conditions.
We next performed 2D native-PAGE analysis to examine the assem-
bly of these newly-translated protein subunits into their respective
OXPHOS complexes (Fig. 1C). In control Mm cybrid mitochondria at
0 h chase (top left panel), CO1 is found in a complex IV (CIV) assembly
intermediate (CIVi) and also mature CIV with CO2 and CO3. Cyt b is as-
sembled quickly into the mature complex III dimer (CIII2) with ATP6
and 8 assembled into mature complex V (CV). At this time point the
complex I (CI) subunit ND2 is detected in a ~600 kDa assembly
intermediate.
In comparison, CO1 is detected predominantly in the CIV intermedi-
ate (CIVi) and not mature CIV in Rn xenocybrid mitochondria at 0 h
chase (Fig. 1C, top right panel). Similarly, both cyt b and ND2 are also
found in lower molecular weight assembly intermediates of ~440 and
~400 kDa respectively.
Following 24 h chase, CO1, 2 and 3 have fully assembled into mature
CIV in Mm mitochondria, with ND1, 2, 4 and 5 detected in mature CI
(Fig. 1C, bottom left panel). However, the assembly proﬁle in Rn
xenocybrid mitochondria following 24 h chase was different, with CO1
also detected not only in mature CIV but also in two CIV assembly
intermediates (Fig. 1C, bottom right panel). No mature complex I (CI)
is detectable, with ND2 in ~600 and ~440 kDa complex I intermediates.
Furthermore, cyt b did not assemble into the complex III dimer (CIII2)
and was undetectable following 24 h chase.
These results suggest that the assembly of OXPHOS complexes I, III and
IV is less efﬁcient in Rn xenocybrid mitochondria, with newly-translated
subunits ‘stalled’ in intermediate complexes. Furthermore, unassembled
subunits, such as cyt b, appear to be turned-over.
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Fig. 1. OXPHOS complex assembly is disrupted in Rn xenocybrid cells. (A) Control Mm
cybrid and Rn xenocybrid mitochondria were solubilized in 1% Triton X-100, followed by
BN-PAGE and Western blotting. Steady-state levels of complex I (CI), the complex III
dimer (CIII2) and complex IV (CIV) are reduced in Rn xenocybrid mitochondria.
(B) MtDNA-encoded subunits in control Mm cybrid and Rn xenocybrid cells were pulse
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To determine if the OXPHOS assembly and activity defects in Rn
xenocybrids have any effects on cell death induction, we treated
control Mm cybrid, Rn xenocybrid and LMEB3 mtDNA-less (ρ0) cells
with the protein kinase C inhibitor staurosporine (STS, 150 nM) or
C2-ceramide (ceramide, 25 μM) for 4 h (Fig. 2A). Chromatin conden-
sation (as a marker of cell death) was assessed by Hoechst 33342
staining [35]. Staurosporine treatment resulted in 28.7 ± 9.4% cell
death in control Mm cybrids (Fig. 2A, lane 4) which exhibited classic
apoptotic features, such as plasma membrane blebbing and the
formation of apoptotic bodies (Supplemental Fig. 1). However, Rn
xenocybrid cells were resistant to staurosporine, with only 4.1 ±
0.9% cell death in Rn xenocybrid cells (Fig. 2A, lane 5). LMEB3 ρ0cells were also resistant to staurosporine-induced cell death (lane
6), consistent with previous studies using human ρ0 osteosarcoma
cells [36].
Conversely, ceramide treatment induced a signiﬁcant 12-fold in-
crease in cell death in Rn xenocybrids (16.5 ± 5.2 %) (Fig. 2A, lane
8). This cell death did not exhibit any apoptotic features and was
more consistent with a necrotic phenotype, including increased cell
volume, enlarged nuclei and condensed chromatin (Supplemental
Fig. 1). Ceramide treatment had no effect on control Mm cybrids or
LMEB3 ρ0 cells (Fig. 2A, lanes 7 and 9).
We also treated cells with staurosporine or ceramide in the
presence of the media supplement B-27 (Life Technologies), which
contains a cocktail of antioxidants including catalase, superoxide
dismutase, DL-α tocopherol acetate, L-carnitine HCl and reduced glu-
tathione. In the presence of these antioxidants, ceramide induced
cell death of Rn xenocybrids was completely attenuated (Fig. 2B,
lane 8). Staurosporine induced cell death in control Mm cybrids was
also reduced in the presence of B-27, albeit incompletely (12.1 ±
3.6% death, Fig. 2B, lane 4).
To determine the type of cell death induced by ceramide we inves-
tigated whether chromosomal DNA fragmentation (a hallmark of ap-
optosis) was occurring in Rn xenocybrid cells (Fig. 2C). No DNA
fragmentation was observed after 24 h ceramide treatment in control
Mm cybrids (Fig. 2C, lane 8), Rn xenocybrids (lane 9) or LMEB3 ρ0
cells (lane 10). In comparison, DNA laddering is clearly evident in
control Mm cybrids following 16 h staurosporine treatment (Fig. 2C,
lane 5).
We next determined whether ceramide induced apoptotic cell
death by examining plasma membrane phosphatidylserine exposure
(Fig. 2D). Control Mm cybrid cells exhibited only background
annexin-FITC staining after either 2.5 h (Fig. 2D, lane 3) or 4.5 h
(lane 5) ceramide treatment. Propidium iodide staining detected only
5.6% dead control Mm cybrid cells after 4.5 h ceramide treatment
(data not shown), consistent with our experimental ﬁndings using
Hoechst staining (Fig. 2A). Rn xenocybrid cells exhibited minimal
positive annexin-FITC staining after only 2.5 h ceramide treatment
(2.4 ±0.2%, lane 4) which returned to background levels after 4.5 h
treatment (0.4 ± 0.2%, lane 6). In comparison, 4 h of staurosporine
treatment in control Mm cybrids induced phosphatidylserine exposure
in 16.9 ±2.7% of cells (Fig. 2D, lane 7) but only 2.6 ± 0.3% in Rn
xenocybrids (lane 8).
We also examined whether the apoptotic protease cascade, in
the form of caspase-3 activity, was induced in Rn xenocybrids by
ceramide (Fig. 2E). Treatment of either control Mm cybrid or Rn
xenocybrid cells with ceramide for 6 h did not increase caspase-3
activity compared to untreated cells (Fig. 2E, lanes 3 and 4). This sug-
gests that ceramide induced cell death is independent of the caspase
cascade in these cells, as treatment of control Mm cybrids with
staurosporine for 3 h resulted in a 10-fold induction of caspase-3
activity (Fig. 2E, lane 5).
Taken together, these results suggest that ceramide induced cell
death in Rn xenocybrid cells is not apoptotic but is more consistent
with a necrotic phenotype.3.4. Inhibition of OXPHOS complex III by ceramide in Rn xenocybrid
mitochondria
To determine if ceramide induction of cell death in Rn xenocybrids
was due to direct inhibition of OXPHOS activity, we performed enzy-
matic assays in the presence of 25 μM C2-ceramide (Fig. 3). Complex I
activity was ~30% slower in Rn xenocybrid mitochondria compared to
control Mm mitochondria (as discussed previously [23]) however
this was not signiﬁcantly different (p = 0.28) (Fig. 3A, lanes 1 and
2). Furthermore, this activity was not affected by the presence of
ceramide in either Mm or Rn mitochondria (Fig. 3A, lanes 3 and 4).
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caspase-3 activity is induced in control Mm cybrids in response to STS (lane 5). All histogram data is expressed as mean ± s.d. (n = 3).
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affected by ceramide (Fig. 3B, lanes 3 and 4).
Complex II + III activity was 39% slower in untreated Rn
xenocybrid mitochondria compared to untreated control Mm mito-
chondria (p b 0.05) (Fig. 3C, lanes 1 and 2), with a similar deﬁciency
measured by the complex III assay (p b 0.05) (Fig. 3D, lanes 1 and 2).
Of note, complex II + III activity was almost totally inhibited by
ceramide (3% residual activity) in Rn xenocybrid mitochondria, com-
pared to control Mm mitochondria which were unaffected (Fig. 3C,
lanes 3 and 4). Complex III activity was also reduced in Rn xenocybrid
mitochondria by ceramide, albeit not signiﬁcantly (Fig. 3D, lanes 3
and 4).
The level of ceramide-mediated inhibition of complex II + III ac-
tivity in Rn xenocybrid mitochondria was concentration-dependent,
with an apparent IC50 of ~6.2 μM (Fig. 4A). Control Mm cybrid
mitochondria showed a slight sensitivity to ceramide at the highest
concentration used (~25% inhibition at 50 μM) but this was not
statistically signiﬁcant (p = 0.13).
The substantial ceramide-mediated inhibition of Rn xenocybrid
II + III activity (85% inhibition with 10 μM ceramide) was abolished
by including 10 μM exogenous decylubiquinone (DB) in the II + III
assay (Fig. 4B). Of note, the inclusion of up to 50 μM DB alone (in
the absence of ceramide) had no effect on complex II + III activity
in Mm control or Rn xenocybrid mitochondria (data not shown).
These results show that ceramide can directly inhibit complex III
activity in Rn xenocybrid mitochondria due to species-speciﬁc differ-
ences in complex III composition and structure. In addition, thisinhibition can be rescued by decylubiquinone, suggesting that cer-
amide binding to the ubiquinone site of complex III is enhanced in
the xenocybrid compared with wild-type complex III.3.5. Reactive oxygen species production by complex III is elevated in Rn
xenocybrid mitochondria and further stimulated by ceramide
We next assessed whether ceramide treatment can induce reac-
tive oxygen species generation in Rn xenocybrid mitochondria during
the stimulation of either complex I or complex III activity. Complex
I-mediated DCFH oxidation appeared slightly higher in Rn xenocybrid
mitochondria compared to control Mmmitochondria (Fig. 5A, lanes 1
and 2). However, as per the complex I activity data (Fig. 3A), this
was not a statistically signiﬁcant difference (p = 0.72). Additionally,
the presence of ceramide had no effect on complex I-mediated
DCFH oxidation in either control Mm or Rn mitochondria (Fig. 5A,
lanes 3 and 4).
In the absence of ceramide, the rate of complex III-mediated DCFH
oxidation was 66% higher in Rn xenocybrid mitochondria compared
to control Mm cybrid mitochondria (p b 0.05) (Fig. 5B, lanes 1
and 2). However, the addition of ceramide increased this rate further
by 42% in Rn xenocybrid mitochondria (p b 0.01) (Fig. 5B, lane 4).
Conversely, the presence of ceramide had no effect on DCFH oxidation
by control Mm cybrid mitochondria (p = 0.36) (Fig. 5B, lane 3).
DCFH oxidation was abolished when 10 mM KCN, an inhibitor of
superoxide dismutase [33], was included in the complex III assay
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due to an initial output of superoxide.
These results indicate that the species-speciﬁc differences in Rn
xenocybrid mitochondria result in increased superoxide generation
at complex III which is further elevated in the presence of ceramide.
4. Discussion
Mitochondria play an integral role in cell death signaling of both
apoptotic and necrotic pathways. The intrinsic apoptotic pathway
(also known as the BLC-2 or mitochondrial pathway) is activated by
developmental cues or cytotoxic insults (e.g. increased intracellular
Ca2+ or ROS) which activates pro-apoptotic BCL-2 family members
such as BAX and BAK. In a process which is not yet fully understood,
BAX and BAK induce mitochondrial outer membrane perme-
abilization (MOMP), resulting in the release of pro-apoptotic mole-
cules such as SMAC/DIABLO and cytochrome c into the cytosol [37].
Cytochrome c then induces the formation of the apoptosome and
the activation of caspase-9 [38].
Alternatively, the extrinsic or death receptor pathway (induced
by Fas or TNF receptor ligation) can also promote cell death viamitochondrial signaling. These receptors can recruit and activate the
Fas-associated death domain (FADD) which in turn can activate
caspase-8. Caspase-8 can then cleave BID to form its C-terminal trun-
cated form (tBID) which translocates to the mitochondria to induce
MOMP and downstream caspase activation [38].
Studies using mtDNA-less ρ0 cells have highlighted the impor-
tance of mitochondrial function in apoptotic signaling and execution.
The total lack of OXPHOS in these cells is usually found to increase
resistance to apoptosis induced by various agents [16,36,39–42].
Nevertheless, Wang et al. also showed that human osteosarcoma ρ0
cells can be as sensitive as parental ρ+ cells to TNFα or Fas ligation
if co-treated with actinomycin D [43].
However, these models do not address the question of whether
OXPHOS defects can produce pathologic effects by increasing mito-
chondrial ROS, or by other effects consequent to altered binding of
signaling molecules to the OXPHOS proteins which are largely absent
in the mtDNA depletion models. Most mitochondrial diseases result
from point mutations affecting single gene products, and deletions
or tRNA mutations affecting all gene products (for reviews see
[44,45]). Our results suggest that the pathophysiology of mitochon-
drial diseases could in part result from very different effects on cell
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here direct evidence for an enhanced cytotoxic effect of ceramide
consequent to an altered mtDNA-encoded protein; the apocytochrome
b of complex III.
For these studies we have used our Rn xenocybrid model, where
mismatches between the mouse nuclear-encoded OXPHOS subunits
and the rat mtDNA-encoded subunits results in multiple OXPHOS
defects [23]. Although this model does not directly mimic single path-
ogenic mtDNA mutations, it enables modeling of mtDNA-derived
OXPHOS defects in mouse cells in the face of limitations in current
technology for mtDNA manipulation [22].
Interestingly, although relatively mild enzymatic deﬁciencies of
complex I (~70% residual activity) and complex III (~79%) were mea-
sured in Rn xenocybrid mitochondria, the steady-state levels of both
complexes were virtually undetectable by BN-PAGE (Fig. 1A). This dis-
crepancy may be due to the altered stability of these xeno-complexes.
The multiple amino acid changes in their mtDNA-encoded protein sub-
units will destabilize their structures, however the mature complexes
are still relatively intact and active in vivo. On the other hand, this de-
stabilization results in the complexes falling apart under the BN-PAGE
conditions used, and as such they are not detected in their mature
forms. We have observed this phenomenon previously, whereby mito-
chondrial membrane lipid changes result in the destabilization of theOXPHOS supercomplex, resulting in the loss of themature supercomplex
under certain BN-PAGE conditions [46].
The OXPHOS defects in the Rn xenocybrid cells resulted in reduced
sensitivity to staurosporine-induced cell death with no activation of
caspase-3. This cell death was similar to mouse LMEB3 ρ0 cells, in
agreement with previous reports using human ρ0 cells [36]. These
ﬁndings suggest that staurosporine-induced apoptosis is partly
dependent on OXPHOS function. Conversely, the defective OXPHOS
function in the Rn xenocybrids switched them to a ceramide sensitive
phenotype (with both the control Mm cybrid and ρ0 cells resistant to
ceramide-induced cell death).
The Rn xenocybrid OXPHOS defects were also associated with an
increase in basal H2O2 production. In addition, treatment with
ceramide further inhibited OXPHOS function and increased ROS
production. Most striking was our ﬁnding that the presence of the
824 I.A. Trounce et al. / Biochimica et Biophysica Acta 1827 (2013) 817–825mismatched Rattus cytochrome b gene product increased complex III
inhibition by ceramide, with almost complete abolition of electron
transfer within the complex.
Some controversy exists around observations of ceramide inter-
actions with OXPHOS complexes. Direct assays [20] and indirect
approaches using speciﬁc respiratory chain complex inhibitors
[15,16,19] have implicated complex III as a site of ceramide inhibi-
tion. Other studies have implicated complex I inhibition and have
questioned the ﬁndings of Gudz et al. [20] regarding complex III in-
hibition [21]. It has been noted that ceramide analogs may interact
with cytochrome c in vitro, decreasing the apparent reducibility of
the electron carrier [21,47], but this interaction was not evident
when cytochrome c was added in our assays.
Our data suggests that ceramide interaction with complex III is al-
tered by one or more of the 26 amino acid differences between the
mouse and rat apocytochrome b gene products (Supplementary
Table 1), greatly increasing the inhibition of enzymatic activity
while stimulating ROS production by the complex. Interestingly, this
inhibition could be completely attenuated by addition of the ubiqui-
none analogue decylubiquinone, suggesting that ceramide competes
with ubiquinone for complex III binding and that the Rattus amino
acid substitutions in cytochrome b alter this interaction.
We have modeled the Rattus amino acid changes in cytochrome b
(shown in green) using the structure of bovine complex III with
bound ubiquinone as a template (Supplemental Fig. 2). Although
none of the Rattus amino acid substitutions (red) are of residues that
interact with ubiquinone within its binding sites Qi and Qo, they are
found in a region adjacent to the Qi site that is important for the inter-
action of cytochrome bwith cytochrome c1 (shown in dark blue, Supp.
Fig. 2A). These substitutions are likely to both destabilize holocomplex
III and make the Qi site more accessible to ceramide. In particular,
Rattus amino acid substitutions at positions 229 (Leu) and 232 (Val)
are found directly adjacent to the Qi site (Supplemental Fig. 2B).
Ceramide is commonly regarded as a second messenger in some ap-
optotic pathways, with sphingolipid metabolism recently identiﬁed as
essential for the activation of BAX/BAK-dependent cytochrome c release
[48]. Ceramide-induced cell death can be either caspase-dependent or
independent [49,50] and may or may not result in internucleosomal
DNA cleavage [13,51]. In our Rn xenocybrid model ceramide-induced
cell death lacked the apoptotic signatures of caspase-3 activation and
chromosomal DNA cleavage and was more consistent with regulated
necrosis or ‘necroptosis’ [52]. Unlike apoptosis (which requires ATP),
this form of cell death can be initiated under ATP-depleted condi-
tions [53], as found in our Rn xenocybrid cells.
We also found that ceramide-induced death of Rn xenocybrid cells
could be completely attenuated by antioxidants, suggesting that the
ROS generated is critical for cell death induction. Without scavenging,
this ceramide-induced ROS can lead to cellular damage, including
lipid peroxidation of cellular membranes [54]. The formation of
these lipid hydroperoxides can induce lysosome membrane perme-
abilization, resulting in the leakage of cytotoxic hydrolases into
the cytosol and the induction of cell death [52]. Lipid peroxidation
products can also induce mitochondrial inner membrane perme-
abilization, resulting in the dissipation of Δψm and reduced Ca2+
buffering capacity [55]. This leakage of proteases and Ca2+ into the
cytosol are two important factors that contribute to necroptotic cell
death.
We speculate that the OXPHOS-derived increase in ROS, due to
ceramide inhibition of complex III activity, is the trigger for increased
necroptotic cell death in Rn xenocybrids. Mitochondrial ATP produc-
tion is signiﬁcantly diminished in these cells, yet clearly not more
than in the mouse ρ0 cells (which have no mitochondrial ATP produc-
tion), suggesting reduced ATP production rate is not the primary
cause of ceramide sensitivity in the Rn xenocybrids, although it may
determine the type of cell death in this case. This is supported by
previous ﬁndings using rotenone-inhibition of complex I in humanosteosarcoma cells, where cell death was associated with the in-
creased ROS production more closely than with the decreased ATP
production [56].
5. Conclusions
Few reports have addressed the question of whether defective
OXPHOS activity, consequent to human disease-causing mtDNA muta-
tions, may modulate cell death pathways. One study used cybrids
containing mtDNA complex I gene mutations linked to Leber Heredi-
tary Optic Neuropathy to show a modest increase in sensitivity to cell
death induced by anti-Fas antibodies [7]. Another report found greatly
increased apoptosis and induction of mitochondrial SOD activity in
ﬁbroblasts from patients with the T8993A mutation in the ATP6 gene
(complex V) associated with Leigh's disease/NARP [57]. Our data
supports these observations and suggests one possible mechanism.
In cells with OXPHOS defects, especially complex III defects, mitochon-
drial ceramide may more readily induce cell death, possibly conse-
quent to increased respiratory chain-derived ROS due to competition
with ubiquinone at the binding site of complex III.
Further work is needed to clarify the speciﬁcity of ceramide inter-
action with OXPHOS complexes, in particular complex III, and reasons
for differences observed in ceramide effects between different cell
types, tissues and species.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbabio.2013.03.012.
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